Cell Signaling Technology (CST) delivers rigorously validated research tools to enable reproducible discovery across basic and translational science. Our industry-leading antibody validation pipeline ensures high specificity and performance across key applications, including Western blotting, ELISA, immunofluorescence, and flow cytometry, supported by advanced proteomics and custom solutions.
Here, we highlight the importance of antibody specificity in enabling robust, high-content, and high-throughput assay workflows. Highly specific antibodies minimize background signal and improve contrast, which is essential for accurate automated image analysis. This directly enhances segmentation fidelity and quantitative readouts, enabling reliable detection of biologically relevant changes.
By integrating validated reagents with scalable assay platforms, these approaches improve data quality, reproducibility, and confidence in downstream analyses. Ultimately, this enables more effective target validation, phenotypic screening, and decision-making, accelerating drug discovery efforts.
Christina Theisgen, PhD, Senior Global Product Trainer, Cell Signalling Technology